Status:
COMPLETED
The Munich Adrenaline Cancer Study
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
Helmholtz Zentrum München
Conditions:
Childhood Cancer
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Observational studies report associations between physical activity and survival in some types of adult cancer. In addition, some exercise-induced molecules such as catecholamines (e.g., adrenaline) a...
Detailed Description
Exercise is generally recommended as an adjunct therapy for adult cancer patients as it counteracts the adverse effects of cancer and its treatment. According to epidemiological data, exercise is also...
Eligibility Criteria
Inclusion
- newly diagnosed pediatric cancer or relapse
- aged 6-18 years
- between the first and third cycle of chemotherapy
- diagnosis and treatment at the Kinderklinik München Schwabing, Department of Paediatrics and Children's Cancer Research Centre, Technical University of Munich
- German language
- informed consent as documented by signature
Exclusion
- Any medical contraindication with respect to a high-intensity interval exercise intervention (e.g., cardiovascular complications, comorbidities, bleeding risk, pain, infection, nausea, orthopedic impairment of the lower extremities)
- inability to follow the procedures and understand the intervention and assessment of the study, e.g., due to cognitive impairment, language problems, psychological disorders etc.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04847908
Start Date
March 1 2018
End Date
May 31 2021
Last Update
October 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kinderklinik München Schwabing, TUM School of Medicine, Department of Paediatrics and Children's Cancer Research Center, Technical University of Munich, Germany
Munich, Germany, 80804